îæ€çŽ¢
îæ€çŽ¢
î
Unicycive Therapeutics Inc
UNCYîãŠã©ãããªã¹ãã«è¿œå
5.010USD
-0.290-5.47%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
126.44Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
詳现æ å ± Unicycive Therapeutics Inc äŒæ¥å
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Unicycive Therapeutics Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãUNCY
äŒç€ŸåUnicycive Therapeutics Inc
äžå Žæ¥Jun 17, 2021
æé«çµå¶è²¬ä»»è
ãCEOãGupta (Shalabh)
åŸæ¥å¡æ°22
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jun 17
æ¬ç€Ÿæåšå°4300 El Camino Real, Suite 210
éœåžLOS ALTOS
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94022
é»è©±çªå·16503840642
ãŠã§ããµã€ãhttps://unicycive.com/
äŒæ¥ã³ãŒãUNCY
äžå Žæ¥Jun 17, 2021
æé«çµå¶è²¬ä»»è
ãCEOãGupta (Shalabh)
Unicycive Therapeutics Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
Mr. Doug Jermasek
Mr. Doug Jermasek
Executive Vice President - Corporate Strategy
Executive Vice President - Corporate Strategy
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
ãããã質å
Unicycive Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îUnicycive Therapeutics Incã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Sandeep (Steve) Laumas, M.D.
Unicycive Therapeutics IncïŒUNCYïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãUnicycive Therapeutics Incã®æ ªåŒãä¿æããŠããæ©é¢ã¯75瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ9.56Mã§ãå
šäœã®35.81%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯450872.00å¢å ããŠããŸãã